RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announces the launch of its fresh-stored osteochondral (OC) allograft line at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Francisco this week. Fresh-stored OC allografts provide mature hyaline cartilage with subchondral bone for resurfacing articular cartilage damage in the knee.

More: continued here

This entry was posted on Saturday, March 15th, 2008 at 12:03 am and is filed under Bones. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.